(Q80272756)

English

Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels

scientific article published on 15 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Klug TL

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Bågeman E

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ingvar C

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Rose C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jernström H

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

15 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

89

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

381-389

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Estrogen metabolites and the risk of breast cancer in older women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Diet and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Association of caffeine intake and CYP1A2 genotype with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Monoclonal antibody-based enzyme immunoassay for simultaneous quantification of 2- and 16α-hydroxyesterone in urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Application of an improved ELISA assay to the analysis of urinary estrogen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

4-Hydroxylation of estrogens as marker of human mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Influence of estrogen metabolism on proliferation of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Tissue-specific synthesis and oxidative metabolism of estrogens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Coffee consumption and breast cancer risk amongBRCA1 andBRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.005

7 January 2021

Identifiers

10.1016/J.YMGME.2006.08.005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16978896%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80272756&oldid=1743763205"